Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 3.93B | 3.99B | 4.26B | 3.92B | 3.20B | 3.18B |
Gross Profit | 833.16M | 911.14M | 1.05B | 927.64M | 680.52M | 659.00M |
EBITDA | 428.91M | 511.44M | 671.70M | 550.21M | 320.03M | 305.00M |
Net Income | 287.11M | 332.06M | 426.20M | 345.38M | 200.17M | 200.00M |
Balance Sheet | ||||||
Total Assets | 5.80B | 5.67B | 5.60B | 5.18B | 4.58B | 4.20B |
Cash, Cash Equivalents and Short-Term Investments | 2.52B | 2.39B | 1.92B | 1.75B | 1.53B | -106.01M |
Total Debt | 30.00M | 0.00 | 0.00 | 28.02M | 66.02M | 106.01M |
Total Liabilities | 1.12B | 1.17B | 1.41B | 1.39B | 1.13B | 106.01M |
Stockholders Equity | 4.68B | 4.50B | 4.20B | 3.79B | 3.45B | 3.09B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 496.77M | 226.05M | 261.89M | 126.22M | 273.00M |
Operating Cash Flow | 0.00 | 505.42M | 247.38M | 267.96M | 152.63M | 276.00M |
Investing Cash Flow | 0.00 | -34.46M | -34.74M | 2.90M | -18.09M | 93.00M |
Financing Cash Flow | 0.00 | -40.81M | -61.22M | -65.16M | 113.36M | -103.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $1.01T | 18.89 | 11.39% | 1.52% | 4.12% | -14.50% | |
72 Outperform | ¥596.92B | 11.05 | 6.70% | 3.97% | 3.72% | 6.12% | |
71 Outperform | ¥3.26B | 10.39 | 1.85% | -6.10% | -26.21% | ||
69 Neutral | $1.52T | 28.39 | 11.84% | 1.23% | 10.21% | 8.55% | |
69 Neutral | ¥230.62B | 14.12 | 7.50% | 2.70% | 9.13% | 8.47% | |
66 Neutral | ¥260.88B | 122.50 | ― | 29.19% | ― | ||
60 Neutral | $797.03B | 44.60 | 0.84% | 2.41% | -3.95% |